The following post comes from Colin Kreutzer, a 2E at Scalia Law and a Research Assistant at CPIP. By Colin Kreutzer While the vaccines are starting to roll out in […]
[Archived Post] CPIP Roundup – December 2, 2020
Greetings from CPIP Executive Director Sean O’Connor I hope you had an enjoyable, restful Thanksgiving. At CPIP, we’re winding down 2020 while planning our spring and summer events—including biopharma and […]
[Archived Post] CPIP Roundup – September 30, 2020
Greetings from CPIP Executive Director Sean O’Connor As we move through our busy fall season here at CPIP, we are grateful for the efforts of everyone in the George Mason […]
[Archived Post] CPIP Roundup – August 31, 2020
Greetings from CPIP Executive Director Sean O’Connor August has seen the beginning of a highly unusual school year, but I hope everyone is continuing to stay safe. And, since even […]
[Archived Post] CPIP Roundup – July 31, 2020
Greetings from CPIP Executive Director Sean O’Connor I hope summer is seeing you healthy and safe. Over four months have passed since the Washington, D.C., area began to feel the […]
[Archived Post] New Paper Looks at “Ill-Advised Legislative Proposals” to Address Pharmaceutical “Evergreening”
The following post comes from Yumi Oda, an LLM Candidate at Scalia Law and a Research Assistant at CPIP. By Yumi Oda Many believe that drug prices in the U.S. […]
[Archived Post] CPIP Scholars Join Comment Letter to FTC Supporting Evidence-Based Approach to IP Policymaking
On December 21, 2018, CPIP Senior Scholars Jonathan Barnett, Chris Holman, Erika Lietzan, Adam Mossoff, Sean O’Connor, and Kristen Osenga joined a comment letter that was filed with the FTC […]
[Archived Post] New CPIP Policy Brief: An Unwise Move to Discriminate Against Pharmaceutical Patents
CPIP has published a new policy brief entitled An Unwise Move to Discriminate Against Pharmaceutical Patents: Responding to the UN’s Guidelines for Pharmaceutical Patent Examination. The brief, written by CPIP […]